IBDEI0AK ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4925,1,2,0)
 ;;=2^708.5
 ;;^UTILITY(U,$J,358.3,4925,1,5,0)
 ;;=5^Cholinergic Urticaria
 ;;^UTILITY(U,$J,358.3,4925,2)
 ;;=^265460
 ;;^UTILITY(U,$J,358.3,4926,0)
 ;;=708.8^^39^394^4
 ;;^UTILITY(U,$J,358.3,4926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4926,1,2,0)
 ;;=2^708.8
 ;;^UTILITY(U,$J,358.3,4926,1,5,0)
 ;;=5^Exercise Induced Urticaria
 ;;^UTILITY(U,$J,358.3,4926,2)
 ;;=^88159
 ;;^UTILITY(U,$J,358.3,4927,0)
 ;;=757.33^^39^394^6
 ;;^UTILITY(U,$J,358.3,4927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4927,1,2,0)
 ;;=2^757.33
 ;;^UTILITY(U,$J,358.3,4927,1,5,0)
 ;;=5^Urticaria Pigmentosa
 ;;^UTILITY(U,$J,358.3,4927,2)
 ;;=^27472
 ;;^UTILITY(U,$J,358.3,4928,0)
 ;;=708.9^^39^394^5
 ;;^UTILITY(U,$J,358.3,4928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4928,1,2,0)
 ;;=2^708.9
 ;;^UTILITY(U,$J,358.3,4928,1,5,0)
 ;;=5^Generalized Urticaria
 ;;^UTILITY(U,$J,358.3,4928,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,4929,0)
 ;;=454.1^^39^395^1
 ;;^UTILITY(U,$J,358.3,4929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4929,1,2,0)
 ;;=2^454.1
 ;;^UTILITY(U,$J,358.3,4929,1,5,0)
 ;;=5^Varicose Veins W/ Inflammation
 ;;^UTILITY(U,$J,358.3,4929,2)
 ;;=^125435
 ;;^UTILITY(U,$J,358.3,4930,0)
 ;;=454.2^^39^395^2
 ;;^UTILITY(U,$J,358.3,4930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4930,1,2,0)
 ;;=2^454.2
 ;;^UTILITY(U,$J,358.3,4930,1,5,0)
 ;;=5^Varicose Veins W/ Inflammation, Ulcerated
 ;;^UTILITY(U,$J,358.3,4930,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,4931,0)
 ;;=454.0^^39^395^3
 ;;^UTILITY(U,$J,358.3,4931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4931,1,2,0)
 ;;=2^454.0
 ;;^UTILITY(U,$J,358.3,4931,1,5,0)
 ;;=5^Varicose Veins, Ulcerated
 ;;^UTILITY(U,$J,358.3,4931,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,4932,0)
 ;;=998.83^^39^396^4
 ;;^UTILITY(U,$J,358.3,4932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4932,1,2,0)
 ;;=2^998.83
 ;;^UTILITY(U,$J,358.3,4932,1,5,0)
 ;;=5^Non-Healing Surgical Wound
 ;;^UTILITY(U,$J,358.3,4932,2)
 ;;=^304351
 ;;^UTILITY(U,$J,358.3,4933,0)
 ;;=998.59^^39^396^3
 ;;^UTILITY(U,$J,358.3,4933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4933,1,2,0)
 ;;=2^998.59
 ;;^UTILITY(U,$J,358.3,4933,1,5,0)
 ;;=5^Infection(Post Operative)
 ;;^UTILITY(U,$J,358.3,4933,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,4934,0)
 ;;=998.12^^39^396^2
 ;;^UTILITY(U,$J,358.3,4934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4934,1,2,0)
 ;;=2^998.12
 ;;^UTILITY(U,$J,358.3,4934,1,5,0)
 ;;=5^Hematoma(Post Operative)
 ;;^UTILITY(U,$J,358.3,4934,2)
 ;;=^304348
 ;;^UTILITY(U,$J,358.3,4935,0)
 ;;=998.32^^39^396^1
 ;;^UTILITY(U,$J,358.3,4935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4935,1,2,0)
 ;;=2^998.32
 ;;^UTILITY(U,$J,358.3,4935,1,5,0)
 ;;=5^Disruption of ext surg wound
 ;;^UTILITY(U,$J,358.3,4935,2)
 ;;=Disruption of ext surg wound
 ;;^UTILITY(U,$J,358.3,4936,0)
 ;;=701.2^^39^397^1
 ;;^UTILITY(U,$J,358.3,4936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4936,1,2,0)
 ;;=2^701.2
 ;;^UTILITY(U,$J,358.3,4936,1,5,0)
 ;;=5^Acanthosis Nigricans
 ;;^UTILITY(U,$J,358.3,4936,2)
 ;;=^2231
 ;;^UTILITY(U,$J,358.3,4937,0)
 ;;=528.8^^39^397^3
 ;;^UTILITY(U,$J,358.3,4937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4937,1,2,0)
 ;;=2^528.8
 ;;^UTILITY(U,$J,358.3,4937,1,5,0)
 ;;=5^Apthous Stomatitis
 ;;^UTILITY(U,$J,358.3,4937,2)
 ;;=^86127
 ;;^UTILITY(U,$J,358.3,4938,0)
 ;;=277.30^^39^397^2
 ;;^UTILITY(U,$J,358.3,4938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4938,1,2,0)
 ;;=2^277.30
 ;;^UTILITY(U,$J,358.3,4938,1,5,0)
 ;;=5^Amyloidosis NOS
 ;;^UTILITY(U,$J,358.3,4938,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,4939,0)
 ;;=136.1^^39^398^1
